Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing and effect of C5a antagonist with ANCA-associated vasculitis

Dosing and effect of C5a antagonist with ANCA-associated vasculitis

US Patent 12350263 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating pancreatic cancer2024
Method of treating C3 glomerulopathy2023
FcRn antibodies and methods of use thereof2022
Method of treating C3 glomerulopathy2022
Dosing and effect of C5a antagonist with ANCA-associated vasculitis2021
Dosing and effect of C5a antagonist with ANCA-associated vasculitis2021
Dosing and effect of C5a antagonist with ANCA-associated vasculitis2021
Methods of treating pancreatic cancer2021
Methods of treating pancreatic cancer2020
Methods of treating pancreatic cancer2019
Method of treating pancreatic cancer2019
Method of treating pancreatic cancer2019